Thursday, April 19, 2018
Pharma Advancement
  • Home
  • News

    CPhI & P-MEC China 2018: Build lucrative pharma business partnerships in China

    More Than 60% of Drug Safety Experts Plan To Use AI to Improve the Speed and Security of Adverse Event Case Processing

    Sanofi, Novonordisk and Novartis Iran are 2018’s Best Places to Work in Iran

    Sanofi, Novonordisk and Novartis Iran are 2018’s Best Places to Work in Iran

    Chemspec Europe 2018:Introduction of Partnering Programme adds new level of networking

    EMA Advises Recall of AbbVie, Biogen MS Drug

    EMA Advises Recall of AbbVie, Biogen MS Drug

    Novartis’ take on what to expect as tech transforms healthcare

    Pfizer encourages public to view and listen webcast of its presentation at Healthcare conference

    Pfizer encourages public to view and listen webcast of its presentation at Healthcare conference

    Merck and Eisai collaborate to develop and sell Eisai cancer drug

    Shire announce its Pivotal study for Hereditary Angioedema at 2018 AAAAI/WAO Joint Congress

  • Market Moves
    Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

    Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

    Alexon pharmaceuticals brings updates on its FY18 Earnings Guidance

    FDA Approves Avycaz for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

    Ablynx Enters €3.9bn Acquisition Deal With Sanofi

    Top Employer”2018- Sanofi

    Sanofi initiates Tender Offer for purchasing Bioverativ Inc

    Roche secure shares in tender offer for Ignyta, Inc

    Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

    Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

    Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris

    Agilent Expands Cell Analysis Portfolio with Acquisition of Luxcel Biosciences

  • Press Statements
  • White Papers
  • Events & Exhibitions
  • Contact Us
No Result
View All Result
  • Home
  • News

    CPhI & P-MEC China 2018: Build lucrative pharma business partnerships in China

    More Than 60% of Drug Safety Experts Plan To Use AI to Improve the Speed and Security of Adverse Event Case Processing

    Sanofi, Novonordisk and Novartis Iran are 2018’s Best Places to Work in Iran

    Sanofi, Novonordisk and Novartis Iran are 2018’s Best Places to Work in Iran

    Chemspec Europe 2018:Introduction of Partnering Programme adds new level of networking

    EMA Advises Recall of AbbVie, Biogen MS Drug

    EMA Advises Recall of AbbVie, Biogen MS Drug

    Novartis’ take on what to expect as tech transforms healthcare

    Pfizer encourages public to view and listen webcast of its presentation at Healthcare conference

    Pfizer encourages public to view and listen webcast of its presentation at Healthcare conference

    Merck and Eisai collaborate to develop and sell Eisai cancer drug

    Shire announce its Pivotal study for Hereditary Angioedema at 2018 AAAAI/WAO Joint Congress

  • Market Moves
    Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

    Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

    Alexon pharmaceuticals brings updates on its FY18 Earnings Guidance

    FDA Approves Avycaz for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

    Ablynx Enters €3.9bn Acquisition Deal With Sanofi

    Top Employer”2018- Sanofi

    Sanofi initiates Tender Offer for purchasing Bioverativ Inc

    Roche secure shares in tender offer for Ignyta, Inc

    Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

    Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

    Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris

    Agilent Expands Cell Analysis Portfolio with Acquisition of Luxcel Biosciences

  • Press Statements
  • White Papers
  • Events & Exhibitions
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Market Moves

Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

Content Team by Content Team
19th January 2018
in Market Moves
Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

Organovo Holdings, Inc. will host a conference call on Thursday, February 8, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company’s fiscal third-quarter 2018 financial results. In advance of the call on February 8, 2018, Organovo will issue its fiscal third-quarter 2018 earnings press release, which will be available at http://www.organovo.com. To participate in the teleconference, callers can dial the following numbers:

To help ensure the conference call begins in a timely manner, please dial in five minutes prior to the scheduled start time. The conference call will also be simultaneously webcast at http://www.organovo.com

For those unable to participate in the live call, a replay of the call will be available toll-free until February 15, 2018 at 1-877-344-7529 (U.S. callers only) or at 1-412-317-0088 (callers outside the U.S.). The passcode for the replay is: 10115734. An archived replay of the webcast will also be available at http://www.organovo.com

About Organovo Holdings, Inc.
Organovo designs and creates functional, three-dimensional human tissues for use in drug discovery, clinical development, and therapeutic applications. The Company develops 3D human tissue systems through internal research programs and in collaboration with pharmaceutical, academic and other partners. Organovo’s 3D human tissues have the potential to transform the drug discovery process, enabling treatments to be developed more effectively and with greater relevance to performance in human trials and commercialization. The Company’s ExVive™ Human Liver and Kidney Tissues are used in high-value drug profiling, including compound screening in disease models, toxicology, target and marker discovery/validation, and other drug testing. The Company is also advancing a preclinical program to develop its NovoTissues® liver therapeutic tissues for critical unmet medical needs, including certain life-threatening pediatric diseases. In addition to numerous scientific publications, the Company’s technology has been featured in The Wall Street Journal, Time Magazine, The Economist, Forbes, and numerous other media outlets. Organovo is changing the shape of life science research and transforming medical care. Learn more at www.organovo.com

Investor Contact:
Steve Kunszabo
Organovo Holdings, Inc.
+1 (858) 224-1092
skunszabo@organovo.com

Press Contact:
Jessica Yingling
Little Dog Communications
+1 (858) 480-2411
jessica@litldog.com

Previous Post

Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium

Next Post

Herbalife Nutrition Survey Reveals APAC Consumers Concerned About Aging-Related Health Issues but Underestimate the Importance of Nutrition in Healthy Aging

Related Posts

Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy
Market Moves

Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

22nd March 2018
Market Moves

Alexon pharmaceuticals brings updates on its FY18 Earnings Guidance

5th March 2018
Featured

FDA Approves Avycaz for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

10th February 2018
Featured

Ablynx Enters €3.9bn Acquisition Deal With Sanofi

10th February 2018
Top Employer”2018- Sanofi
Market Moves

Sanofi initiates Tender Offer for purchasing Bioverativ Inc

9th February 2018
Market Moves

Roche secure shares in tender offer for Ignyta, Inc

9th February 2018
Next Post

Herbalife Nutrition Survey Reveals APAC Consumers Concerned About Aging-Related Health Issues but Underestimate the Importance of Nutrition in Healthy Aging

Latest News

Clinical Trials

BERG Announces the Dosing of First UK Patient in Phase II Combination Trial of BPM 31510 and Gemcitabine for Patients with Pancreatic Cancer

6th April 2018
Asia

CPhI & P-MEC China 2018: Build lucrative pharma business partnerships in China

3rd April 2018
Americas

More Than 60% of Drug Safety Experts Plan To Use AI to Improve the Speed and Security of Adverse Event Case Processing

23rd March 2018
Press Statements

Prothena Announces Global Neuroscience R&D Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases

23rd March 2018
Clinical Trials

Roche’s TECENTRIQ plus chemotherapy reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced squamous lung cancer: Phase III IMpower131 study

23rd March 2018
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • News
  • Market Moves
  • Press Statements
  • White Papers
  • Events & Conferences

Resources

  • Advertise with us
  • Contact Us

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Download Media Pack

Close

x
No Result
View All Result
  • Home
  • News
  • Market Moves
  • Press Statements
  • White Papers
  • Events & Exhibitions
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In